For more information, contact Abbott.
For more information, contact Abbott.
| PRODUCT NAME | UNIT SIZE | ORDER NUMBER | GTIN |
|---|
The LSI BCR/ABL Dual Color, Single Fusion Translocation Probe is intended to identify the BCR/ABL gene fusion resulting from the t(9;22)(q34;q11.2) or other chromosomal rearrangements. The probe may be used with metaphase chromosomes or interphase nuclei.
The SpectrumOrange ABL1 probe extends from a point between ABL1 exons 4 and 5 and extends for approximately 190 kb toward the 9q telomere. This probe target flanks the expected chromosome 9 breakpoint in t(9;22)(q34;q11.2). The SpectrumGreen BCR probe begins between BCR exons 13 and 14 (major breakpoint cluster region [M-bcr] exons 3 and 4) and extends toward the chromosome 22 centromere for approximately 287 kb. The BCR probe flanks the expected M-bcr breakpoints, but spans the minor breakpoint cluster region (m-bcr) for t(9;22)(q34;q11.2).
A nucleus lacking the t(9;22) will exhibit the two orange, two green (2O2G) signal pattern. In a cell harboring the t(9;22), one orange, one green, and one orange/ green (yellow) fusion signal pattern (1O1G1F) will be observed. This simple probe design detects the 5’ BCR/3’ ABL gene fusion and is useful for detecting samples with a high percentage of cells possessing this translocation.
Normal Hybridization: LSI BCR/ABL Dual Color, Single Fusion Translocation Probe hybridized to a nucleus containing the t(9;22). One orange, one green and one fusion (IOIGIF) signal pattern is observed.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.